Initial Results From the Early Feasibility Study of the Edwards Left Atrial to Coronary Sinus Apture Transcatheter Shunt System
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Grant Support/Research Contract - Conformal; Edwards Lifesciences
- Consultant Fee/Honoraria/Speaker's Bureau - Intact Vascular; Shockwave; W.L. Gore & Associates; Boston Scientific Corporation; Medtronic; Philips